Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago
100 mg
1 x 10
৳50.00

Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.

All price changes →

Save on this medicine

Same active ingredient — pay up to 10% less

These brands contain the same active ingredient (Flibanserin). Same strength and form. Confirm the switch with your doctor or pharmacist.

From ৳50.00 (1 x 10)
Available as: 100 mg · 1 x 10 100 mg 100 mg 100 mg

Indications & Uses

Fevigra tablet is indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to: A co-existing medical or psychiatric condition Problems within the relationship, or The effects of a medication or other drug substance

Dosage Reference

Reference Information Only

Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.

Adults:

Recommended dosage of Flibanserin: 100 mg taken once daily at bedtime.Pediatric Use: Not recommended in patients below 18 years of age.Geriatric Use: Flibanserin is not indicated for use in geriatric patients. Safety and effectiveness have not been established in geriatric patients.

Side Effects

Most common side effects are Dizziness, Somnolence, Nausea, Fatigue, Insomnia, Dry mouth.

Cautions & Contraindications

Warnings & Precautions

Patients with pre-syncope should immediately lie supine and promptly seek medical help if symptoms do not resolve. Exacerbated by other CNS depressants and in settings where Fevigra concentrations are increased. Patients should avoid activities requiring full alertness (e.g., operating machinery or driving) until at least 6 hours after each dose and until they know how Fevigra affects them.

Contraindications

Flibanserin is contraindicated: With use of alcohol, With concomitant use with moderate or strong CYP3A4 inhibitors, In patients with hepatic impairment.

Drug Interactions

Open checker →
Moderate Digoxin
Last updated: 18 Aug 2026